As the first financial year ends on 31 December 2019, this financial report represents the combined financial statement and activities of GARDP carried out in DNDi and GARDP for the 12 months period ending 31 December 2019.
Antimicrobial resistance, one of the world’s biggest killers, has reached an alarming tipping point.
Changing the way antibiotics are developed and accessed.
A public-health driven model to tackle AMR.
Our latest news and resources.
Protecting people from the rise and spread of drug-resistant infections.
Supporting efforts to ensure the right antibiotics are developed and reach the people who need them.